Skip to main content
Top
Published in: Annals of Hematology 6/2017

01-06-2017 | Letter to the Editor

Idiopathic hypereosinophilic syndrome manifesting with eosinophilic cholecystitis and recurrent gastroenteritis

Authors: Yutaka Shimazu, Hiromitsu Nagata

Published in: Annals of Hematology | Issue 6/2017

Login to get access

Excerpt

Dear Editor, …
Literature
4.
5.
go back to reference Jovanovic JV, Score J, Waghorn K et al (2007) Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia. Blood 109:4635–4640. doi:10.1182/blood-2006-10-050054 CrossRefPubMed Jovanovic JV, Score J, Waghorn K et al (2007) Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia. Blood 109:4635–4640. doi:10.​1182/​blood-2006-10-050054 CrossRefPubMed
6.
go back to reference Weller PF, Bubley GJ (1994) The idiopathic hypereosinophilic syndrome. Blood 83:2759–2779PubMed Weller PF, Bubley GJ (1994) The idiopathic hypereosinophilic syndrome. Blood 83:2759–2779PubMed
8.
go back to reference Felman RH, Sutherland DB, Conklin JL, Mitros FA (1994) Eosinophilic cholecystitis, appendiceal inflammation, pericarditis, and cephalosporin-associated eosinophilia. Dig Dis Sci 39:418–422CrossRefPubMed Felman RH, Sutherland DB, Conklin JL, Mitros FA (1994) Eosinophilic cholecystitis, appendiceal inflammation, pericarditis, and cephalosporin-associated eosinophilia. Dig Dis Sci 39:418–422CrossRefPubMed
9.
go back to reference Shakov R, Simoni G, Villacin A, Baddoura W (2007) Case report: eosinophilic cholecystitis, with a review of the literature. Ann Clin Lab Sci 37:182–185PubMed Shakov R, Simoni G, Villacin A, Baddoura W (2007) Case report: eosinophilic cholecystitis, with a review of the literature. Ann Clin Lab Sci 37:182–185PubMed
Metadata
Title
Idiopathic hypereosinophilic syndrome manifesting with eosinophilic cholecystitis and recurrent gastroenteritis
Authors
Yutaka Shimazu
Hiromitsu Nagata
Publication date
01-06-2017
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 6/2017
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-017-2989-7

Other articles of this Issue 6/2017

Annals of Hematology 6/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.